Clinical Trial Update: CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial (CONVERT-HB1) evaluating radical prostatectomy after systemic therapy for patients with high-volume metastatic hormone-sensitive prosta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-sensitive Prostate Cancer
• Prostate Cancer

Snippet

Sponsor: Fudan University | Conditions: Metastatic Prostate Cancer, Prostate Cancer (Adenocarcinoma) | Phase 2 | Status: NOT_YET_RECRUITING